Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
mRNA-1273 Emergency use authorization Experimental Vaccine Jul/11/2022 28 1
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
PF-00835231 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 5 1
Silibinin Potential treatment - theoretical effect Natural product Antiviral Apr/06/2021 2 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Excel (.xslx) CSV (.csv)